Virus-mediated oncolysis induces danger signal and stimulates cytotoxic T-lymphocyte activity via proteasome activator upregulation. - Wikidata - awgldk - TriplyDB

Virus-mediated oncolysis induces danger signal and stimulates cytotoxic T-lymphocyte activity via proteasome activator upregulation.

Virus-mediated oncolysis induces danger signal and stimulates cytotoxic T-lymphocyte activity via proteasome activator upregulation.

http://www.wikidata.org/entity/Q40056582

about

Oncolytic viruses as therapeutic cancer vaccines Oncolytic viruses as anticancer vaccines Tumor-specific delivery of biologics by a novel T-cell line HOZOT.Complementary induction of immunogenic cell death by oncolytic parvovirus H-1PV and gemcitabine in pancreatic cancer Oncolytic Viruses for Cancer Therapy: Overcoming the Obstacles.Identification of genetically modified Maraba virus as an oncolytic rhabdovirus.Armed oncolytic virus enhances immune functions of chimeric antigen receptor-modified T cells in solid tumors.Lymphokine-activated killer and dendritic cell carriage enhances oncolytic reovirus therapy for ovarian cancer by overcoming antibody neutralization in ascites Increasing the efficacy of oncolytic adenovirus vectors Oncolytic viruses: a novel form of immunotherapy.The case of oncolytic viruses versus the immune system: waiting on the judgment of Solomon.Maraba virus as a potent oncolytic vaccine vector.Oncolytic (replication-competent) adenoviruses as anticancer agents.Oncolytic Immunotherapy: Dying the Right Way is a Key to Eliciting Potent Antitumor Immunity.Oncolytic Adenoviruses Armed with Tumor Necrosis Factor Alpha and Interleukin-2 Enable Successful Adoptive Cell Therapy.Evolution of oncolytic viruses: novel strategies for cancer treatment.Armed therapeutic viruses - a disruptive therapy on the horizon of cancer immunotherapy.Chemotherapy and Oncolytic Virotherapy: Advanced Tactics in the War against Cancer.Changing faces in virology: the dutch shift from oncogenic to oncolytic viruses.Immunogenic cell death by oncolytic herpes simplex virus type 1 in squamous cell carcinoma cells.Enhanced antitumor efficacy of telomerase-specific oncolytic adenovirus with valproic acid against human cancer cells.Impact of Autophagy in Oncolytic Adenoviral Therapy for Cancer.Potent antitumor effects of combined therapy with a telomerase-specific, replication-competent adenovirus (OBP-301) and IL-2 in a mouse model of renal cell carcinoma.Role of autophagy in oncolytic herpes simplex virus type 1-induced cell death in squamous cell carcinoma cells.Adenoviral production of interleukin-2 at the tumor site removes the need for systemic postconditioning in adoptive cell therapy.Prospects for combined use of oncolytic viruses and CAR T-cells.Proteomic Analysis of Secretomes of Oncolytic Herpes Simplex Virus-Infected Squamous Cell Carcinoma Cells.Oncolytic Virotherapy and the Tumor Microenvironment.Capitalizing on Cancer Specific Replication: Oncolytic Viruses as a Versatile Platform for the Enhancement of Cancer Immunotherapy Strategies.Human dendritic cells efficiently phagocytose adenoviral oncolysate but require additional stimulation to mature.Genetically engineered oncolytic adenovirus induces autophagic cell death through an E2F1-microRNA-7-epidermal growth factor receptor axis.Targeting Autophagy for Oncolytic Immunotherapy.

P2860

Q21245758-F7621990-382C-4B78-8BDC-641171EC3AAA Q27025600-4FAB9720-03AC-4B4A-A9CB-0B14055D019F Q30830225-854B94A4-1B54-47C6-A56B-6C599216301F Q33602876-B3F3D2AA-8A34-468D-AACB-0A52014A9AC6 Q33906116-EE174042-650C-4CB4-A5AB-52963D6AA6C3 Q34080860-42EA6726-E11E-41E6-B8E0-A0201F56A5B8 Q34205181-CE3368A0-6C66-4225-8E6A-831431EAEFDF Q35061974-8B9316AE-5640-4EAF-BCBE-3D93BE96CADF Q35261325-8BB3FBE3-DBE5-4452-968A-AB06C60F131F Q37300008-6A233386-6ED3-4FE6-9DE9-33B7596D66D1 Q37561072-8EE7D9A8-F6FF-4485-AF59-432CCDB9578E Q37562080-9E820A23-CED0-46DA-A41C-EA1562D36B5F Q37687415-8D7F4B5B-9474-4EC3-B9CA-9EAF98726AAE Q37707676-D63E90EB-34F2-4347-97AE-EC388ED335E0 Q37718529-23B3A2B6-0DF1-4E87-A078-DF17CC83AEF9 Q38159802-F826DA43-3D44-42E6-BB07-7DA373BD3D2A Q38194135-7061F410-9A37-4A64-90AB-FCCAB7525D5D Q38223419-269DCB9F-8CAF-490C-B46B-E2F13D071F7E Q38241666-7A95D379-5503-4759-A90F-BBE027B6D045 Q38785456-B2AF5F02-09C2-4014-9FF6-6B11E0B10A95 Q39283903-A6D4F5BC-00F2-4D5A-881E-45DD6C0493D8 Q39429511-189DE778-2673-46DC-8EB6-033BCC57B5A9 Q39737611-AB67FDC1-B630-420C-AB87-7DA525D91FE3 Q41922999-0DA25501-B414-4103-851C-AA3D3E733276 Q41963078-E4253BBD-D750-4564-91D1-D6FB5D6B202C Q47103891-D8E3C9B4-A5D3-4B88-896D-14AB3AA2D304 Q47549912-FDA23E53-84B7-4FFA-983C-334FB99043C1 Q47560690-CC5D0CB7-2AEB-4FDA-813A-34F29767EE44 Q50865520-3390532A-1F5F-4543-9330-0972E89CC120 Q53809292-58F44A9D-1C53-4531-9ECC-3E7147CE1472 Q54315299-020B4428-F603-43A8-B3B8-DD0DDB972698 Q55171421-2C333EE2-474B-4EC6-A479-66495C3063EB

P2860

Virus-mediated oncolysis induces danger signal and stimulates cytotoxic T-lymphocyte activity via proteasome activator upregulation.

http://www.wikidata.org/entity/Q40056582

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Virus-mediated oncolysis induc ...... easome activator upregulation.

@en

type

label

Virus-mediated oncolysis induc ...... easome activator upregulation.

@en

prefLabel

Virus-mediated oncolysis induc ...... easome activator upregulation.

@en

P1433

Q40056582-10717798-8E5A-443E-BD36-9BCD8662F348

P1476

Q40056582-2B6E4692-F5CA-4F40-9B22-3672040D44FF

P2093

Q40056582-0F82B05B-F8F3-46B6-A1F8-6C51CE6D1125

Q40056582-1404CD1A-B25D-4A1E-8714-A174BC369AFF

Q40056582-3785096E-BB37-4A75-AE2E-DDBF5489C6F6

Q40056582-3F9602EE-A676-492A-A820-3243EF421DE1

Q40056582-87D88A22-47B9-40B8-AD59-36312F7E5A20

Q40056582-AD4DD979-C071-443C-86B3-077430081748

Q40056582-B5D2AE8F-1215-4E83-9F20-5215B24EEAFF

Q40056582-C9811A5B-113D-4BCA-9FE2-5E8DF45D60A6

Q40056582-E726C433-10E3-4AF3-8989-F958BC3FFA21

Q40056582-EFFE4F19-631A-4CF6-9B45-7F7A0F9CED8C

P2860

Q40056582-30D50FE0-A551-418A-9C67-3E00D8E2EC6D

Q40056582-44192E8C-1394-4D61-A364-0DA5FBA56FEB

Q40056582-44EF707E-9D7B-4994-BBDB-FF57CF6F902F

Q40056582-511F50DB-1547-4EDC-827C-B0C17E922DA6

Q40056582-5569A0AC-AC4E-434D-9854-A1074E16ED13

Q40056582-621FA54C-FC40-4548-AB8D-78822E64C664

Q40056582-68BA4F87-0B65-4368-BD20-D6F824FFCCD1

Q40056582-70651968-97CA-4AE5-B095-FC1E6D7106CD

Q40056582-7069B564-458F-4D95-AE23-477526F8FA7F

Q40056582-70D1D6AE-40B7-42A4-A551-107E22721161

P2888

Q40056582-CC6DFC24-CE21-4731-BA8E-4BA20CE2A021

P304

Q40056582-1E1518C6-897E-4007-95A6-AC61C1017E00

P31

Q40056582-DC383BBB-3B78-47AD-87A8-159DBE0D5853

P356

Q40056582-692C8DF8-A351-48D0-9E91-F376BD24470E

P407

Q40056582-5F743D2E-69F9-429F-A269-F1C310397B87

P433

Q40056582-BD11FA56-6B77-47C5-9CE0-BA6C2D4909DB

P478

Q40056582-6588A2ED-7805-4206-8BB2-22CB7292EC4C

P577

Q40056582-C2C8BE35-9440-48BB-89D8-D9D9B76AE3F8

P5875

Q40056582-7643EF26-0EF5-4B22-AA0E-384A0AD57902

P6179

Q40056582-6BFF3BF1-4BDF-4BA3-8390-F112B0F43BBF

P698

Q40056582-1FCD5ED8-9007-44C9-87C3-28F89287C675

P921

Q40056582-E1741DEA-88DB-46EB-95AD-8A6B10A3A6B4

P356

P1433

P1476

Virus-mediated oncolysis induc ...... easome activator upregulation.

@en

P2093

Endo Y

http://www.w3.org/2001/XMLSchema#string

Fujiwara T

http://www.w3.org/2001/XMLSchema#string

Hioki M

http://www.w3.org/2001/XMLSchema#string

Kagawa S

http://www.w3.org/2001/XMLSchema#string

Onimatsu H

http://www.w3.org/2001/XMLSchema#string

Ouchi M

http://www.w3.org/2001/XMLSchema#string

Sakai R

http://www.w3.org/2001/XMLSchema#string

Tanaka N

http://www.w3.org/2001/XMLSchema#string

Uno F

http://www.w3.org/2001/XMLSchema#string

Urata Y

http://www.w3.org/2001/XMLSchema#string

P2860

The induction of tolerance by dendritic cells that have captured apoptotic cells

Viral oncolysis: increased immunogenicity of host cell antigen associated with influenza virus

The role of the proteasome activator PA28 in MHC class I antigen processing

Molecular identification of a danger signal that alerts the immune system to dying cells

Infection of human dendritic cells by dengue virus causes cell maturation and cytokine production.

Visualization of intrathoracically disseminated solid tumors in mice with optical imaging by telomerase-specific amplification of a transferred green fluorescent protein gene.

Uric acid and oxidative stress.

Antiviral therapy for adenovirus infections.

HSP110 induces "danger signals" upon interaction with antigen presenting cells and mouse mammary carcinoma.

Enhanced oncolysis by a tropism-modified telomerase-specific replication-selective adenoviral agent OBP-405 ('Telomelysin-RGD').

P2888

P304

2375-2381

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.ONC.1210884

http://www.w3.org/2001/XMLSchema#string

P407

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P577

2007-11-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5865149

http://www.w3.org/2001/XMLSchema#string

P6179

1018407855

http://www.w3.org/2001/XMLSchema#string

P698

17982491

http://www.w3.org/2001/XMLSchema#string

P921